07.10.2018 Issue 409

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

Pfizer Delivers Another Round of Price Hikes

Thursday, July 5

Pfizer has increased prices on 100 drugs to mark its second round of price hikes this year, according to Fierce Pharma.

Survey: 100% of Respondents Save Money with Value-Based Models

ResearchAndMarkets.Com Offers Global HEOR Services Report

Report: Look Beyond HIPAA for 21st Century Healthy Information Privacy

Article Spotlights Barriers in Big Data, Predictive Analytics

ICER Releases Final Report on CGRP Inhibitors for Migraine Prevention

MHE Looks at Trump’s Drug Pricing Strategy

UDG Healthcare Buys Two U.S. Firms for $82 Million

Associate Research Director-PS8789

Researcher or Senior Researcher-PS8321

Director, HealthCore Biostatistics-PS7682)

Research Data Assistant Senior (Data Manager)-PS8215

Research Data Coordinator (Data Manager II)-PS8213

Research Data Manager (PS7307)

U.S. Market Access and Contracting Manager

Scientific Director, IMEDS

Industry Spotlight

Conferences Webinars
One-Day Workshop on R for Trial and Model-Based Cost-Effectiveness Analysis
    July 11, London, U.K.

Innovative Strategies for Patient Centered Clinical Research
    July 11-12, Boston, Massachusetts

    July 11-12, Philadelphia, Pennsylvania

Health Econometrics Workshop
    July 16-19, Bergamo, Italy

Improving HCEI Communication: Publication Planning Professionals Are Key Partners in Building Successful HCEI Exchange
    July 18

Advancing Drug Development and Outcomes Research with Artificial Intelligence, Machine Learning, and Predictive Models
    July 18

Industry Perceptions and Expectations: The Role of ICER as an Independent HTA
    July 31

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Biosimilars: U.S. Payer Perspectives

KAM Metrics: Driving Efficiency, Measuring Success

Biosimilars: E.U. Payer Perspectives

MSL Teams: Field Force Size and Structure

Taking a Total View: Linking Pharmacy + Medical Drug Trends

Reinventing Claims Payment for a Value-Based World

Payers that Engage Members See Better Health Outcomes, Savvier Spending

Seeing the Value and Transparency of Medicare Part B

A Framework to Guide the Optimal Development and Use of Real World Evidence for Coverage and Formulary Decisions

Improve Quality Measures with mPulse Mobile Solutions

Special Thanks to Our Partners:
   Evidera    G&J Lee RecruitmentHealthCoreMAPSUniversity of FL
              Truven    XcendaOM1Parexel   Jefferson
      Dymaxium        Precision Xtract    Pharmerit    eMax Health
SciformixEvidence PartnersICON